Suppr超能文献

苯并咪唑-硫代喹啉衍生物的合成及构效关系研究作为α-葡萄糖苷酶抑制剂。

Synthesis and structure-activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors.

机构信息

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Sci Rep. 2023 Mar 16;13(1):4392. doi: 10.1038/s41598-023-31080-2.

Abstract

In this article, different s-substituted benzimidazole-thioquinoline derivatives were designed, synthesized, and evaluated for their possible α-glucosidase inhibitory activities. The most active compound in this series, 6j (X = 4-bromobenzyl) exhibited significant potency with an IC value of 28.0 ± 0.6 µM compared to acarbose as the positive control with an IC value of 750.0 µM. The kinetic study showed a competitive inhibition pattern against α-glucosidase for the 6j derivative. Also, the molecular dynamic simulations were performed to determine key interactions between compounds and the targeted enzyme. The in silico pharmacodynamics and ADMET properties were executed to illustrate the druggability of the novel derivatives. In general, it can be concluded that these derivatives can serve as promising leads to the design of potential α-glucosidase inhibitors.

摘要

在本文中,设计、合成了不同的 S-取代苯并咪唑-硫代喹啉衍生物,并评估了它们可能的α-葡萄糖苷酶抑制活性。在这一系列中最活跃的化合物 6j(X=4-溴苄基)表现出显著的效力,IC 值为 28.0±0.6 μM,与阳性对照阿卡波糖的 IC 值为 750.0 μM 相比。动力学研究表明,6j 衍生物对α-葡萄糖苷酶呈竞争性抑制模式。此外,还进行了分子动力学模拟以确定化合物与靶酶之间的关键相互作用。通过计算药理学和 ADMET 性质来阐明新型衍生物的成药性。总的来说,可以得出结论,这些衍生物可以作为设计潜在的α-葡萄糖苷酶抑制剂的有前途的先导化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782e/10020548/ab07dc9524aa/41598_2023_31080_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验